142
Views
6
CrossRef citations to date
0
Altmetric
Letters to the Editor

Soluble RANKL production by leukemic cells in a case of chronic lymphocytic leukemia with bone destruction

, , , , , , , , , , , , & show all
Pages 2468-2471 | Received 15 Sep 2015, Accepted 29 Jan 2016, Published online: 25 Feb 2016

References

  • Schmiedel BJ, Scheible CA, Nuebling T, et al. RANKL expression, function, and therapeutic targeting in multiple myeloma and chronic lymphocytic leukemia. Cancer Res. 2012;73:683–694.
  • Barcala V, Ruybal P, Garcia Rivello H, et al. RANKL expression in a case of follicular lymphoma. Eur J Haematol. 2003;70:417–419.
  • Pangalis GA, Moutsopoulos HM, Papadopoulos NM, et al. Monoclonal and oligoclonal immunoglobulins in the serum of patients with B-chronic lymphocytic leukemia. Acta Haematol. 1988;80:23–27.
  • Beaume A, Brizard A, Dreyfus B, et al. High incidence of serum monoclonal Igs detected by a sensitive immunoblotting technique in B-cell chronic lymphocytic leukemia. Blood. 1994;84:1216–1219.
  • Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008.
  • Stanganelli C, Travella A, Bezares R, et al. Immunoglobulin gene rearrangements and mutational status in argentinian patients with chronic lymphocytic leukemia. Clin Lymphoma Myeloma Leuk. 2013;13:447–457. e442.
  • Travella A, Ripolles L, Aventin A, et al. Structural alterations in chronic lymphocytic leukaemia. Cytogenetic and FISH analysis. Hematol Oncol. 2013;31:79–87.
  • Scheven BA, Visser JW, Nijweide PJ. In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population. Nature. 1986;321:79–81.
  • Ibbotson KJ, Roodman GD, McManus LM, et al. Identification and characterization of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cells. J Cell Biol. 1984;99:471–480.
  • Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93:165–176.
  • Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA. 1998;95:3597–3602.
  • Lacey DL, Tan HL, Lu J, et al. Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am J Pathol. 2000;157:435–448.
  • Delpino MV, Barrionuevo P, Macedo GC, et al. Macrophage-elicited osteoclastogenesis in response to Brucella abortus infection requires TLR2/MyD88-dependent TNF-α production. - production. J Leukoc Biol. 2012;91:285–298.
  • Hallek M, Cheson BD, Catovsky D, et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008;111:5446–5456.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.